Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03100474 · ClinicalTrials.gov registry record
Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:
A clinical trial of Parkinson's Disease and Essential Tremor, sponsored by InSightec.
- Active
- Registry status
- 500
- Enrollment target
- 9
- Study locations
NCT03100474: Active study of Parkinson's Disease and Essential Tremor, sponsored by InSightec.
NCT03100474 is a study of Parkinson's Disease and Essential Tremor that is active but no longer recruiting, run by InSightec. The registered enrollment target is 500 participants, below the 632-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (21% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03100474, a study of Parkinson's Disease and Essential Tremor, is active but no longer recruiting, sponsored by InSightec.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 9
- Study locations
Study Summary
A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.
Primary Outcome
CRST
Conditions Studied
Study Locations (9)
Other
- Rambam Healthcare Campus - Haifa
- Sheba Medical Center - Ramat Gan
- Chang Bing Show Chwan Memorial Hospital - Chang-hua
California
- Stanford University - Stanford
Maryland
- University of Maryland - Baltimore
Pennsylvania
- University of Pennsylvania - Philadelphia
Virginia
- University of Virginia - Charlottesville
Washington
- Swedish Neuroscience Institute - Seattle
Ontario
- Sunnybrook - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-12 |
| Est. Completion | 2026-06 |
What the registry record for NCT03100474 still lists
NCT03100474 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 632-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (21% lower).
The record links to 4 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03100474 lists 9 locations in 7 states (Other, California, Maryland).
Frequently Asked Questions
What is clinical trial NCT03100474 about?
NCT03100474 is a clinical study titled "Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:". A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.
What is the current status of trial NCT03100474?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2016-12. Estimated completion is 2026-06.
What conditions does trial NCT03100474 study?
This clinical trial studies the following conditions: Parkinson's Disease, Essential Tremor, Neuropathic Pain, Movement Disorders.
Who is sponsoring clinical trial NCT03100474?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03100474 being conducted?
This trial has 9 study locations across California, Maryland, Pennsylvania, Virginia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03100474's enrollment target sits among peer trials
500 18th of 158 higher than 141 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia